Dosing Penalty of Erythropoiesis-Stimulating Agents after Switching from Originator to Biosimilar Preparations in Stable Hemodialysis Patients

American Journal of Kidney Diseases

Volumn 68, Issue 1, 2016, Pages 170-172

  Minutolo, Roberto ^a   Borzumati, Maurizio ^b   Sposini, Stefano ^c   Abaterusso, Cataldo ^d   Carraro, Gianni ^e   Santoboni, Alberto ^f   Mura, Carlo ^g   Filiberti, Oliviero ^h   Santoro, Domenico ⁱ   Musacchio, Romano ^j   Imperiali, Patrizio ^k   Fiorini, Fulvio ^l   De Nicola, Luca ^a   Russo, Domenico ^m  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Castelli Hospital   (Italy)

^c SS Giacomo e Cristoforo Hospital   (Italy)

^d Nuclear Medicine PET Center   (Italy)

^e UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^f Nephrology and Dialysis Unit   (Italy)

^g Department of Radiology Santa Maria alla Gruccia Hospital   (Italy)

^h SANT'ANDREA HOSPITAL   (Italy)

ⁱ UNIVERSITY OF MESSINA   (Italy)

^j Cardiology Unit   (Italy)

^k Arezzo Hospital   (Italy)

^l Rovigo Hospital   (Italy)

^m UNIVERSITY OF NAPLES FEDERICO II   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; BIOSIMILAR AGENT; HEMOGLOBIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; SB 309; UNCLASSIFIED DRUG; ERYTHROPOIETIN; IRON; RECOMBINANT PROTEIN; TRACE ELEMENT;

ANEMIA; AREA UNDER THE CURVE; DRUG SURVEILLANCE PROGRAM; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LETTER; AGED; CHRONIC KIDNEY FAILURE; COMPLICATION; DOSE RESPONSE; DRUG SUBSTITUTION; FEMALE; IRON DEFICIENCY ANEMIA; MALE; METABOLISM; MIDDLE AGED; RETROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANEMIA; ANEMIA, IRON-DEFICIENCY; BIOSIMILAR PHARMACEUTICALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SUBSTITUTION; EPOETIN ALFA; ERYTHROPOIETIN; FEMALE; HEMATINICS; HEMOGLOBINS; HUMANS; IRON; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TRACE ELEMENTS;

EID: 84957615076     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2016.01.011     Document Type: Letter

References (10)

1. M. Haag-Weber, A. Vetter, U. Thyroff-Friesinger INJStudy Group Therapeutic equivalence, long-term efficacy and safety of HX575 in the treatment of anemia in chronic renal failure patients receiving hemodialysis Clin Nephrol 72 5 2009 380 390
2. S. Krivoshiev, V. Wizemann, S. Czekalsk, and et al. Therapeutic equivalence of epoetin zeta and alfa, administered subcutaneously, for maintenance treatment of renal anemia Adv Ther 27 2 2010 105 117
3. S. Krivoshiev, V. Todorov, J. Manitius, and et al. Comparison of the therapeutic effects of epoetin zeta and epoetin alfa in the correction of renal anaemia Curr Med Res Opin 24 5 2008 1407 1415
4. W.H. Hörl, F. Locatelli, M. Haag-Weber, M. Ode, K. Roth Epo-PASS Study Group Prospective multicenter study of HX575 (biosimilar epoetin-α) in patients with chronic kidney disease applying a target hemoglobin of 10-12 g/dl Clin Nephrol 78 1 2012 24 32
5. V. Wizemann, B. Rutkowski, C. Baldamus, P. Scigalla, R. Koytchev Epoetin Zeta Study Group Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment Curr Med Res Opin 24 3 2008 625 637
6. I. Koulouridis, M. Alfayez, T.A. Trikalinos, E.M. Balk, and B.L. Jaber Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis Am J Kidney Dis 61 1 2013 44 56
7. S. Elliott, J. Egrie, J. Browne, and et al. Control of rHuEPO biological activity: the role of carbohydrate Exp Hematol 32 12 2004 1146 1155
8. F. Sörgel, U. Thyroff-Friesinger, A. Vetter, B. Vens-Cappell, and M. Kinzig Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple IV administrations: an open-label randomized controlled trial BMC Clin Pharmacol 9 2009 10
9. A. Mikhail, and M. Farouk Epoetin biosimilars in Europe: five years on Adv Ther 30 1 2013 28 40
10. S.C. Palmer, V. Saglimbene, D. Mavridis, and et al. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis Cochrane Database Syst Rev 12 2014 CD010590